Search research articles
Contact Us
Filters
Showing results (231-240 of 260) with videos related to
Page
of 26
Sort By:
Nature
|
September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness
Fei Mo, Zhiya Yu, Peng Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
Maria R Parkhurst, James C Yang, Russell C Langan, et al.
Immunity
|
December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signature
Pawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
Cell Reports
|
March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
Raul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Cancer Research
|
September 23, 2017
ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer
Vivek Shukla, Mahadev Rao, Hongen Zhang, et al.
The Journal of Experimental Medicine
|
September 4, 2013
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells
Christopher A Klebanoff, Sean P Spencer, Parizad Torabi-Parizi, et al.
Cell Reports
|
August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approach
Rigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2010
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
Mark E Dudley, Colin A Gross, Michelle M Langhan, et al.
Elife
|
May 23, 2015
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
Bernard Khor, John D Gagnon, Gautam Goel, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 260) with videos related to
Sort By:
Page
of 26
Nature
|
September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness
Fei Mo, Zhiya Yu, Peng Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
Maria R Parkhurst, James C Yang, Russell C Langan, et al.
Immunity
|
December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signature
Pawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
Cell Reports
|
March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
Raul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Cancer Research
|
September 23, 2017
ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer
Vivek Shukla, Mahadev Rao, Hongen Zhang, et al.
The Journal of Experimental Medicine
|
September 4, 2013
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells
Christopher A Klebanoff, Sean P Spencer, Parizad Torabi-Parizi, et al.
Cell Reports
|
August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approach
Rigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2010
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
Mark E Dudley, Colin A Gross, Michelle M Langhan, et al.
Elife
|
May 23, 2015
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
Bernard Khor, John D Gagnon, Gautam Goel, et al.
Page
of 26